About Careers Internship MedBlog Contact us
Medindia LOGIN REGISTER
Advertisement

Ibuprofen Use Reduces Bladder Cancer Risk

by VR Sreeraman on November 9, 2012 at 2:23 PM
Font : A-A+

 Ibuprofen Use Reduces Bladder Cancer Risk

A new study has found that using ibuprofen on a regular basis may help reduce risk of bladder cancer, especially in those with certain genetic marker.

In a 2012 collaborative project with the National Cancer Institute, Margaret Karagas, PhD, co-director, Cancer Epidemiology and Chemoprevention program at Norris Cotton Cancer Center, and Professor of Community and Family Medicine at the Geisel School of Medicine at Dartmouth, and Richard Waddell, D.Sc, Research Assistant Professor of Medicine at the Geisel School of Medicine, looked for connections between ibuprofen use and bladder cancer.

Advertisement

Karagas did an earlier study on the relationship between bladder cancer and nonsteroidal anti-inflammatory drugs (NSAIDs) usage in New Hampshire.

The new study included patients in Vermont and Maine. Researchers enrolled 1,171 participants newly diagnosed with bladder cancer and 1,418 participants who did not have bladder cancer. Karagas also added a genetic component looking at thirty-nine genes related to NSAID metabolism and studied a new class of NSAIDs known as selective cyclooxygenase (COX-2) inhibitors, such as celecoxib (Celebrex).
Advertisement

The findings in the recent study suggested that "regular use of nonaspirin nonselective NSAIDs, particularly ibuprofen, may reduce bladder cancer risk, especially among regular users for 10 years or more."

However, the study also noted that observed reduction in risk was specific to individuals carrying a specific allele (or variant of a gene) related to NSAID metabolism.

For Karagas one of the novel findings was a trend of an increased risk of bladder cancer for those using selective COX-2 inhibitors, especially celocoxib (Celebrex).

But Karagas warns against leaping to any conclusions, noting, "further investigation is needed."

Karagas also stresses that this study "does not make any recommendations. It does not, in any way, suggest that patients begin taking ibuprofen as a prophylactic measure against bladder cancer, nor should patients go off any medicine prescribed by their doctor."

Their results were published in the International Journal of Cancer (June 2012).

Source: ANI
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
What's New on Medindia
Test Your Knowledge on Liver Transplantation
Organ Donation Week 2022 - 'Take the Pledge to Save Lives'
Test your Knowledge on Heart Transplantation
View all
Recommended Reading
News Archive
Date
Category
Advertisement
News Category

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Cancer and Homeopathy Vesico-Ureteric Reflux Causing UTI in Children Enuresis/Bedwetting Cancer Facts Cancer Tattoos A Body Art Interstitial Cystitis Bladder Cancer Costochondritis Common Lifestyle Habits that Cause Diseases 

Most Popular on Medindia

Selfie Addiction Calculator Blood Donation - Recipients Sinopril (2mg) (Lacidipine) Drug - Food Interactions Daily Calorie Requirements A-Z Drug Brands in India Noscaphene (Noscapine) Indian Medical Journals Blood Pressure Calculator Turmeric Powder - Health Benefits, Uses & Side Effects
This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use